{
    "clinical_study": {
        "@rank": "65318", 
        "arm_group": [
            {
                "arm_group_label": "Orfadin capsules, fasting", 
                "arm_group_type": "Active Comparator", 
                "description": "Orfadin capsules, single dose, 30 mg"
            }, 
            {
                "arm_group_label": "Orfadin suspension, fasting", 
                "arm_group_type": "Experimental", 
                "description": "Orfadin suspension 4 mg/mL, single dose 30 mg (7,5 mL)"
            }, 
            {
                "arm_group_label": "Orfadin suspension, with food", 
                "arm_group_type": "Experimental", 
                "description": "Orfadin suspension 4mg/mL, single dose 30 mg (7,5 mL)"
            }
        ], 
        "brief_summary": {
            "textblock": "The study is primarily being performed in order to demonstrate bioequivalence between the\n      Orfadin (nitisinone) suspension and the marketed capsule formulation. The study will also\n      contain a comparison of the bioavailability of the suspension given with food and on an\n      empty stomach."
        }, 
        "brief_title": "Bioequivalence of Orfadin Suspension Compared to Orfadin Capsules, and the Effect of Food on the Bioavailability of the Suspension", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "All treatment arms", 
                        "title": "Overall Study"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "12"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "12"
                                            }
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "12", 
                                            "@value": "35"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "12"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "12"
                                        }
                                    }, 
                                    "sub_title": "Netherlands"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "0.81", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "90", 
                                "ci_upper_limit": "0.91", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "non_inferiority": "Yes", 
                                "non_inferiority_desc": "Bioequivalence was established if the 90% confidence interval of the ratio was completely within the acceptance range (0.80-1.25)", 
                                "param_type": "Ratio of geometric means", 
                                "param_value": "0.858"
                            }
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin capsules, single dose, 30 mg", 
                                    "title": "Orfadin Capsules, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "12"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "315", 
                                                        "@upper_limit": "500", 
                                                        "@value": "403"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "264", 
                                                        "@upper_limit": "456", 
                                                        "@value": "346"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Geometric Mean", 
                                    "title": "The Area Under the Serum Concentration Curve (AUC) During 72 Hours After Dose (AUC72h) During Fasting Conditions.", 
                                    "units": "uM*h"
                                }
                            ]
                        }, 
                        "population": "Full analysis set was used; subjects with available PK data for at least one of the treatments.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "The Area Under the Serum Concentration Curve (AUC) During 72 Hours After Dose (AUC72h) During Fasting Conditions.", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "0.85", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "90", 
                                "ci_upper_limit": "1.07", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "non_inferiority": "Yes", 
                                "non_inferiority_desc": "Bioequivalence was established if the 90% confidence interval of the ratio was completely within the acceptance range (0.80-1.25)", 
                                "param_type": "Ratio of geometric means", 
                                "param_value": "0.954"
                            }
                        }, 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin capsules, single dose, 30 mg", 
                                    "title": "Orfadin Capsules, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "12"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "8030", 
                                                        "@upper_limit": "18000", 
                                                        "@value": "10213"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "7780", 
                                                        "@upper_limit": "20300", 
                                                        "@value": "9741"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "dispersion": "Full Range", 
                                    "param": "Geometric Mean", 
                                    "title": "The Maximum Serum Concentration (Cmax) During Fasting Conditions.", 
                                    "units": "nM"
                                }
                            ]
                        }, 
                        "population": "Full analysis set was used; subjects with available PK data for at least one of the treatments.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "The Maximum Serum Concentration (Cmax) During Fasting Conditions.", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "0.96", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "90", 
                                "ci_upper_limit": "1.07", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "non_inferiority": "Yes", 
                                "non_inferiority_desc": "Equivalence (no food effect) was established if the 90% confidence interval of the ratio was completely within the acceptance range (0.80 - 1.25).", 
                                "param_type": "Ratio of geometric means", 
                                "param_value": "1.013"
                            }
                        }, 
                        "description": "Measured for the Orfadin suspension treatments arms- both fasting and with food.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, With Food"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "264", 
                                                        "@upper_limit": "456", 
                                                        "@value": "346"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "251", 
                                                        "@upper_limit": "467", 
                                                        "@value": "350"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Measured for the Orfadin suspension treatments arms- both fasting and with food.", 
                                    "dispersion": "Full Range", 
                                    "param": "Geometric Mean", 
                                    "title": "The Area Under the Serum Concentration Curve (AUC) During 72 Hours After Dose (AUC72h)", 
                                    "units": "uM*h"
                                }
                            ]
                        }, 
                        "population": "Full analysis set was used; subjects with available PK data for at least one of the treatments.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "The Area Under the Serum Concentration Curve (AUC) During 72 Hours After Dose (AUC72h)", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "0.71", 
                                "ci_n_sides": "2-Sided", 
                                "ci_percent": "90", 
                                "ci_upper_limit": "0.90", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "non_inferiority": "Yes", 
                                "non_inferiority_desc": "Equivalence (no food effect) was established if the 90% confidence interval of the ratio was completely within the acceptance range (0.80 - 1.25)", 
                                "param_type": "Ratio of geometric means", 
                                "param_value": "0.802"
                            }
                        }, 
                        "description": "Measured for the Orfadin suspension treatment arms- both fasting and with food.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, With Food"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "7780", 
                                                        "@upper_limit": "20300", 
                                                        "@value": "9741"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "5300", 
                                                        "@upper_limit": "12500", 
                                                        "@value": "7808"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Measured for the Orfadin suspension treatment arms- both fasting and with food.", 
                                    "dispersion": "Full Range", 
                                    "param": "Geometric Mean", 
                                    "title": "The Maximum Serum Concentration (Cmax)", 
                                    "units": "nM"
                                }
                            ]
                        }, 
                        "population": "Full analysis set was used; subjects with available PK data for at least one of the treatments.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "The Maximum Serum Concentration (Cmax)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin capsules, single dose, 30 mg", 
                                    "title": "Orfadin Capsules, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, With Food"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "366", 
                                                        "@upper_limit": "891", 
                                                        "@value": "633"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "454", 
                                                        "@upper_limit": "715", 
                                                        "@value": "559"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "417", 
                                                        "@upper_limit": "858", 
                                                        "@value": "577"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                                    "dispersion": "Full Range", 
                                    "param": "Geometric Mean", 
                                    "title": "AUC From Time Zero to Infinity", 
                                    "units": "h*uM"
                                }
                            ]
                        }, 
                        "population": "Per-protocol set (bioequivalence) was used for fasted treatment groups and per-protocol set (food effect) for fed treatment group (all subjects with available PK data)", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "AUC From Time Zero to Infinity", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin capsules, single dose, 30 mg", 
                                    "title": "Orfadin Capsules, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose 30 mg (7,5 mL)", 
                                    "title": "Orfadin Suspension, With Food"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.75", 
                                                        "@upper_limit": "8.00", 
                                                        "@value": "3.50"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.25", 
                                                        "@upper_limit": "4.00", 
                                                        "@value": "0.38"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "3.50", 
                                                        "@upper_limit": "10.00", 
                                                        "@value": "8.00"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Time to Reach C-Max (t-Max)", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Per protocol set (bioequivalence) was used for fasting treatments and per protocol set (food effect) used for fed treatment (all subjects with available PK data)", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "Time to Reach C-Max (t-Max)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin capsules, single dose, 30 mg", 
                                    "title": "Orfadin Capsules, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7.5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7.5 mL)", 
                                    "title": "Orfadin Suspension, With Food"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "20.6", 
                                                        "@upper_limit": "66.4", 
                                                        "@value": "48.7"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "39.3", 
                                                        "@upper_limit": "63.7", 
                                                        "@value": "53.6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "37.3", 
                                                        "@upper_limit": "75.6", 
                                                        "@value": "54.3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Terminal Half-life", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Per protocol set (bioequivalence) was used for fasting treatments and per protocol set (food effect) used for fed treatment (all subjects with available PK data)", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "Terminal Half-life", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin capsules, single dose, 30 mg", 
                                    "title": "Orfadin Capsules, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension, 4 mg/mL, single dose, 30 mg (7.5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7.5 mL)", 
                                    "title": "Orfadin Suspension, With Food"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.102", 
                                                        "@upper_limit": "0.249", 
                                                        "@value": "0.145"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.127", 
                                                        "@upper_limit": "0.201", 
                                                        "@value": "0.160"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "0.106", 
                                                        "@upper_limit": "0.218", 
                                                        "@value": "0.158"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Oral Clearance (CL/F)", 
                                    "units": "L/h"
                                }
                            ]
                        }, 
                        "population": "Per protocol set (bioequivalence) was used for fasting treatments and per protocol set (food effect) used for fed treatment (all subjects with available PK data)", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "Oral Clearance (CL/F)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Orfadin capsules, single dose, 30 mg", 
                                    "title": "Orfadin Capsules, Fasting"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7.5 mL)", 
                                    "title": "Orfadin Suspension, Fasting"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7.5 mL)", 
                                    "title": "Orfadin Suspension, With Food"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "7.42", 
                                                        "@upper_limit": "12.0", 
                                                        "@value": "9.80"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "8.59", 
                                                        "@upper_limit": "16.7", 
                                                        "@value": "12.2"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "8.48", 
                                                        "@upper_limit": "17.2", 
                                                        "@value": "12.8"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Apparent Volume of Distribution (Vz/F)", 
                                    "units": "L"
                                }
                            ]
                        }, 
                        "population": "Per protocol set (bioequivalence) was used for fasting treatments and per protocol set (food effect) used for fed treatment (all subjects with available PK data)", 
                        "safety_issue": "No", 
                        "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose.", 
                        "title": "Apparent Volume of Distribution (Vz/F)", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "All participants received all study treatments in a randomized fashion. Subjects were allocated to one of the following treatment sequences (2 subjects to each sequence):\nA B C; B C A; C A B; C B A; A C B; B A C where A=Orfadin capsules, single dose, 30 mg; B=Orfadin suspension, single dose 30 mg, fasting; C=Orfadin suspension, single dose 30 mg, fed", 
                        "title": "All Treatment Groups"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "12", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "12", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "recruitment_details": "First subject screened: 29 August 2012 Last subject last visit: 25 October 2012."
            }, 
            "point_of_contact": {
                "email": "erik.brouwer@sobi.com", 
                "name_or_title": "Medical Director", 
                "organization": "Swedish Orphan Biovitrum", 
                "phone": "+4686972000"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Orfadin capsules, single dose, 30 mg", 
                            "title": "Orfadin Capsules, Fasting"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7.5 mL)", 
                            "title": "Orfadin Suspension, Fasting"
                        }, 
                        {
                            "@group_id": "E3", 
                            "description": "Orfadin suspension 4 mg/mL, single dose, 30 mg (7.5 mL)", 
                            "title": "Orfadin Suspension, With Food"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "12"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "12"
                                            }
                                        ], 
                                        "sub_title": "Dyspepsia"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "12"
                                            }
                                        ], 
                                        "sub_title": "Catheter site related reaction"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "12"
                                            }
                                        ], 
                                        "sub_title": "Nasopharyngitis"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "12"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "12"
                                            }
                                        ], 
                                        "sub_title": "Musculoskeletal pain"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "12"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "12"
                                                }, 
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "12"
                                                }
                                            ], 
                                            "sub_title": "Dizziness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "12"
                                                }, 
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "12"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "12"
                                                }
                                            ], 
                                            "sub_title": "Headache"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "12"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "12"
                                                }, 
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "12"
                                                }
                                            ], 
                                            "sub_title": "Epistaxis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "12"
                                                }, 
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "12"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E3", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "12"
                                                }
                                            ], 
                                            "sub_title": "Nasal congestion"
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 15.0", 
                    "frequency_threshold": "0"
                }
            }
        }, 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Volunteers", 
        "detailed_description": {
            "textblock": "This is an open, randomized 3-way crossover study in 12 healthy volunteers. Subjects will\n      receive single oral 30-mg doses of nitisinone as a suspension (fasting and with food) and as\n      hard gelatin capsules (fasting only). There will be a 2-week washout period between the\n      doses.\n\n      There will be a screening visit within 3 weeks prior to the first dose. During each\n      treatment period, subjects will be admitted to the clinic from the afternoon on the day\n      before drug administration (i.e., on Day -1) and remain at the clinic until the 48-hour\n      post-dose blood sample has been collected in the morning of Day 3. They will then return for\n      ambulatory visit in the morning of Day 4 (72-hour sample). A follow-up visit will take place\n      7-14 days after the last dose."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male volunteers\n\n          -  Age: 18-55 years, inclusive\n\n          -  BMI: 18,5-30,0 kg/m2, inclusive\n\n        Exclusion Criteria:\n\n          -  heavy smokers\n\n          -  Consumption of more than 4 cups of coffee per day.\n\n          -  History of drug and/or alcohol abuse.\n\n          -  Positive drug screen or alcohol breath test.\n\n          -  Positive screens for hepatitis B surface antigen, hepatitis C antibodies and human\n             immunodeficiency virus (HIV) 1-2 antibodies.\n\n          -  Enrollment in another concurrent clinical study\n\n          -  Intake of an investigational medicinal product within three months prior to inclusion\n             in this study.\n\n          -  Donation of more than 50 mL of blood within 60 days prior to drug administration\n\n          -  Donation of more than 1,5 liters of blood in the 10 months prior to first drug\n             administration."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 7, 2012", 
        "firstreceived_results_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01682538", 
            "org_study_id": "Sobi.NTBC-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Orfadin capsules, fasting", 
                "intervention_name": "Nitisinone, capsule", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Orfadin suspension, fasting", 
                    "Orfadin suspension, with food"
                ], 
                "intervention_name": "Nitisinone, suspension", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Nitisinone"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Orfadin", 
            "Nitisinone", 
            "Bioequivalence", 
            "Bioavailability"
        ], 
        "lastchanged_date": "February 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zuidlaren", 
                    "country": "Netherlands"
                }, 
                "name": "Pharmaceutical Research Associates Group B.V (PRA)"
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Study to Evaluate the Bioequivalence of Orfadin Suspension 4 mg/mL Compared to Orfadin Capsules 10 mg, and the Effect of Food on the Bioavailability of the Suspension. An Open-label, Randomized, Cross-over, Single-dose Study in Healthy Volunteers", 
        "overall_official": {
            "affiliation": "Swedish Orphan Biovitrum", 
            "last_name": "Erik Brouwer, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "The Area Under the Serum Concentration Curve (AUC) During 72 Hours After Dose (AUC72h) During Fasting Conditions.", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }, 
            {
                "measure": "The Maximum Serum Concentration (Cmax) During Fasting Conditions.", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01682538"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measured for the Orfadin suspension treatments arms- both fasting and with food.", 
                "measure": "The Area Under the Serum Concentration Curve (AUC) During 72 Hours After Dose (AUC72h)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }, 
            {
                "description": "Measured for the Orfadin suspension treatment arms- both fasting and with food.", 
                "measure": "The Maximum Serum Concentration (Cmax)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }, 
            {
                "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                "measure": "AUC From Time Zero to Infinity", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }, 
            {
                "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                "measure": "Time to Reach C-Max (t-Max)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }, 
            {
                "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                "measure": "Terminal Half-life", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }, 
            {
                "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                "measure": "Oral Clearance (CL/F)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }, 
            {
                "description": "Measured for the Orfadin capsules and suspension treatments arms - both fasting and with food.", 
                "measure": "Apparent Volume of Distribution (Vz/F)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 predose and at 15, 30, 45 minutes and 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 12, 24, 36, 48 and 72 hours postdose."
            }
        ], 
        "source": "Swedish Orphan Biovitrum", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Swedish Orphan Biovitrum", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}